483 Merck & Sep 2013

483 Merck & Sep 2013

Marcelo Mangalindan FDA$119.00 - Available Now

FDA investigators audited the Merck & - Ambler, PA, United States facility and issued inspectional observations (via FDA 483) on 27 Sep 2013.

Product details

  • Category: Human Drugs
  • Inspection end: 27 Sep 2013
  • Location: Ambler, United States
  • FEI: 3010391293
Add To Cart